Trace elements and superoxide dismutase in benign and malignant breast diseases Cüneyt KöksoyGüzin Özelçi KavasCihangir Özarslan Legacy Pages: 01 - 06
Lumpectomy or mastectomy? Is breast conserving surgery too expensive? Jan NorumJan Abel OlsenErik A. Wist Legacy Pages: 07 - 14
Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo Yogendra SinghNobuaki ShikataAiro Tsubura Legacy Pages: 15 - 27
Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170H.82 (Tru-Scint®AD™) Sophie DessureaultIrv KovenSteven Gallinger Legacy Pages: 29 - 37
Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions Paul C. StomperJanet S. WinstonLeslie E. Blumenson Legacy Pages: 39 - 46
Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer A.M. MuradR.C. GuimaraesG. Schwartsmann OriginalPaper Pages: 47 - 53
Gamma-glutamyl transpeptidase immunoreactivity in benign and malignant breast tissue Janet R. DurhamHenry F. Frierson JrMarie H. Hanigan OriginalPaper Pages: 55 - 62
mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy Chang Shu WangHélène LarueBernard Têtu OriginalPaper Pages: 63 - 74
Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia D.W. VisscherF.H. SarkarK.B. Reddy Legacy Pages: 75 - 80
Transforming growth factor-β in breast cancer: A working hypothesis Michael ReissMary Helen Barcellos-Hoff Legacy Pages: 81 - 95
